§16§Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation 〓16§s field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers.
